Oct. 14, 2020
Identifying Patient-specific Flow of Signal Transduction Perturbed by Multiple Single-nucleotide Alterations
Background: Identifying patient-specific flow of signal transduction perturbed by multiple single-nucleotide alterations is critical for improving patient outcomes in cancer cases. However, accurate estimation of mutational effects at the pathway level for such patients remains an open problem. While probabilistic pathway topology methods are gaining interest among the scientific community, the overwhelming majority do not account for network perturbation effects from multiple single-nucleotide alterations. Methods: Here we present an improvement of the Mutational Forks formalism to infer the patient-specific flow of signal transduction based on multiple single-nucleotide alterations, including non-synonymous and synonymous mutations. The lung adenocarcinoma and skin cutaneous melanoma datasets from…
Oct. 2, 2020
Analysis of Healthy Coping Feedback Messages from Diabetes Mobile Apps
To analyze Healthy Coping-related feedback messages from diabetes mobile apps against the theoretical framework based on behavioral change theories. We searched apps using the search terms: “diabetes,” “blood sugar,” “glucose,” and “mood” from iTunes and Google Play stores. We entered a range of values on three Healthy Coping domains: 1) diabetes-related measures, 2) physical exercise/activity, and 3) mood to generate feedback messages. We developed behavioral change theory-based framework and analyzed the feedback messages against three dimensions of timing, intention, and content (feedback purpose and feedback response). The feedback purposes were categorized into seven purposes; warning, suggestion, self-monitoring, acknowledging, reinforcement, goal…
Oct. 2, 2020
Data-Driven Patients Stratification and Drug Repositioning
Cancer is a heterogeneous disease and represents a great example of the need for selecting patient-centric rather than disease-centric treatment. De novo drug discovery is a time-consuming and high-cost process with a low success rate. Drug repositioning (DR) reduces the time, cost, and risk of developing new drugs because it recommends new uses for drugs already declared safe for human use. This study uses a novel data mining approach, exploratory data mining (EDM), and network analysis for patient cohort stratification and DR. This approach enables identifying homogeneous subgroups within a heterogeneous disease population and recommends drugs based on subgroup-specific molecular…
Sep. 28, 2020
Data Analytics Using the Cerner Real-world COVID-19 Data to Answer Clinical Questions
Cerner Real World data allows researchers and data scientists to explore clinical data via HealtheDataLab. Recently, Cerner granted many of their client institutions access to de-identified patient’s data for COVID-19 research to help fight the pandemic. The de-identified patient data was dataset contains COVID-19 related encounters, demographics, chronic conditions, medication, and lab results. This large-scale cohort allows for the investigation of the relationships between risk factors, comorbidities, complication and specific outcomes. However, due to variable accuracy and completeness of data, usage of EHR data for research purposes requires an in-depth understanding of potential pitfalls which could lead to inaccurate or unrepresentative…
Sep. 21, 2020
Improving interpretation of Genome-Wide Association Studies (GWAS) by quantifying Marker Recurrence
To understand biological differences within groups of people or animals, we often turn to DNA. A genome-wide association study (GWAS) can assess the genetic contribution of biological differences between individuals. However, the scale of input data continues to expand in three ways: the sequence coverage of genomes, the number of individuals sequenced, and the number of phenotype records per individual. High-throughput workflows are computationally intensive and require a laborious interpretation of results. These barriers inhibit systematically investigating hypotheses and limit the effective translation of genetics into biomedical and agricultural solutions. The expansion of data analyzed, compounded by numerous analysis approaches,…
Sep. 21, 2020
Implementing GeoARK: The Geospatial Analytical Research Knowledgebase
This research focuses on the development and implementation of an interface to the Geospatial Analytical Research Knowledgebase (GeoARK), a spatially enabled big data informatics approach assembled around applications in health research and analytics. Example applications in telehealth reach, COVID-19 risk in rural situations, pathways for zoonotic disease spread, and contextual leukemia research will be provided. The creation and design of GeoARK occurred within the University of Missouri’s Institute for Data Science and Informatics. Being spatially engendered, its core is data that is pre-processed, cleaned, integrated and represented in its spatial context as millions of point locations. To this core, additional…
Sep. 14, 2020
An R-based platform for the visualization and analysis of single molecule tracking experiments
Single molecule tracking (SMT) is a technique of single-molecule fluorescence imaging that allows for the exploration of molecular motion at a high spatiotemporal resolution on living cells. This is widely used to define dynamics of individual tumor cell-surface receptors. Spatiotemporal regulation of many of these receptors varies across cancer types, playing a key role in tumor progression and drug resistance. Many tools can be used to identify trajectories and calculate their features from these experiments. However, there are relatively few tools to analyze this data. Thus, the present study uses a set of live-cell single-molecule imaging experiments with a model…
May 4, 2020
Cancer Research Funding: Where is the Money?
Cancer is one of the most common and deadly diseases and its incidence is increasing. There are over one hundred types of cancer and they have a varied impact on society and those affected. Some have known, preventable causes and some are poorly understood. Some can be detected early and some are only detected in an advanced stage. Some are very treatable and some have a very high mortality rate. In order to level the playing field for cancers, there needs to be research to understand more about poorly understood cancers. What is the present state of cancer research funding?…
May 4, 2020
Quantifying the Predictive Value of Categories of Neighborhood-Level Risk Factors to Predict Health Outcomes
A person’s environmental context is well known to impact health outcomes. However, this information is rarely available in an acute clinical care setting. Although a growing body of literature combines the information available in the Electronic Medical Record (EMR) with environmental and place-based data to better examine the environmental impact on health, these studies generally focus on a single index or category of environmental data, thus failing to take into account the richness of geo-spatial data that are available, as well as the underlying interactions of multiple community risk factors. Recent improvements in access to geo-spatial data at multiple layers…